Evidence map›Paper›PMID 24084941›Full record

ArticleNature communications2013

Functional lacrimal gland regeneration by transplantation of a bioengineered organ germ.

Masatoshi Hirayama, Miho Ogawa, Masamitsu Oshima, Yurie Sekine, Kentaro Ishida, Kentaro Yamashita, Kazutaka Ikeda, Shigeto Shimmura, Tetsuya Kawakita, Kazuo Tsubota and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Tissue Engineering and Ophthalmology.Turkish journal of ophthalmology · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masatoshi Hirayama1] Department of Ophthalmology, School of Medicine, Keio University, Shinjuku-ku, Tokyo 160 8582, Japan [2] Research Institute for Science and Technology, Tokyo University of Science, Noda, Chiba 278 8510, Japan.
Miho Ogawa
Masamitsu Oshima
Yurie Sekine
Kentaro Ishida
Kentaro Yamashita
Kazutaka Ikeda
Shigeto Shimmura
Tetsuya Kawakita
Kazuo Tsubota
Takashi Tsuji

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lacrimal gland has a multifaceted role in maintaining a homeostatic microenvironment for a healthy ocular surface via tear secretion. Dry-eye disease, which is caused by lacrimal gland dysfunction, is one of the most prevalent eye diseases that cause corneal epithelial damage and results in significant loss of vision and a reduction in the quality of life. Here we demonstrate orthotopic transplantation of bioengineered lacrimal gland germs into adult mice with an extra-orbital lacrimal gland defect, a mouse model that mimics the corneal epithelial damage caused by lacrimal gland dysfunction. The bioengineered lacrimal gland germs and harderian gland germs both develop in vivo and achieve sufficient physiological functionality, including tear production in response to nervous stimulation and ocular surface protection. This study demonstrates the potential for bioengineered organ replacement to functionally restore the lacrimal gland.

Indexed as

Recovery of FunctionRegenerationAnimalsCorneaDry Eye SyndromesEmbryo, MammalianEmbryonic Stem CellsEpithelial CellsGraft SurvivalHarderian GlandLacrimal ApparatusMiceMice, Inbred C57BLPolyglycolic AcidTearsTissue EngineeringPolyglycolic Acid

Identifiers

PMID24084941
PMCPMC3806342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.